⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL992532 | 0.77 | — | — | |
| SCHEMBL8359473 | 0.75 | CALM1 (0.50) | — | |
| Diphenylmethane SCHEMBL28630998 | 0.73 | CALM1 (0.75) | — | |
| SCHEMBL11457819 | 0.73 | ALDH1A1 (0.55) | — | |
| SCHEMBL2032974 | 0.69 | CALM1 (0.50) | — | |
| SCHEMBL2684480 | 0.67 | ALDH1A1 (0.48) | — | |
| SCHEMBL8830370 | 0.67 | CALM1 (0.41) | — | |
| (Chloromethyl)Benzene SCHEMBL7413 | 0.65 | — | — | |
| SCHEMBL21317609 | 0.65 | CALM1 (0.53) | — | |
| (Chloromethyl)Benzene SCHEMBL1331085 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 783 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-8182643-A | — | — | None | — | — | JP | disclosed |
| US-12037585-B2 | Oligonucleotides for tissue specific gene expression modulation | UNIVERSITY OF MASSACHUSETTS (US) | 2024-07-16 | — | — | US | disclosed |
| US-12024706-B2 | Modified oligonucleotides targeting SNPs | UNIVERSITY OF MASSACHUSETTS (US) | 2024-07-02 | — | — | US | disclosed |
| US-20240200061-A1 | TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED OCULAR DISEASES | ALNYLAM PHARMACEUTICALS, INC. | 2024-06-20 | — | — | US | disclosed |
| US-12005074-B2 | Extrahepatic delivery | ALNYLAM PHARMACEUTICALS, INC. (US) | 2024-06-11 | — | — | US | disclosed |
| EP-4376953-A1 | PEPTIDE LIGANDS FOR CNS AND OCULAR DELIVERY OF RNAI COMPOUNDS | Alnylam Pharmaceuticals, Inc. (US) | 2024-06-05 | — | — | EP | disclosed |
| US-20240175028-A1 | DOSING OF siRNA COMPOUNDS TO THE CISTERNA MAGNA | ALNYLAM PHARMACEUTICALS, INC (US) | 2024-05-30 | — | — | US | disclosed |
| EP-4367237-A2 | BIS-RNAI COMPOUNDS FOR CNS DELIVERY | Alnylam Pharmaceuticals, Inc. (US) | 2024-05-15 | — | — | EP | disclosed |
| US-20240141362-A1 | MODIFIED OLIGONUCLEOTIDES WITH INCREASED STABILITY | UNIV MASSACHUSETTS (US) | 2024-05-02 | — | — | US | disclosed |
| US-20240132892-A1 | OLIGONUCLEOTIDE-BASED MODULATION OF C9orf72 | UNIV MASSACHUSETTS (US) | 2024-04-25 | — | — | US | disclosed |
| EP-0810875-A1 | MULTIFUNCTIONAL ENZYME | PHAIRSON MEDICAL INC. (SE) | 1997-12-10 | — | — | EP | disclosed |
| WO-1997045423-A1 | PHARMACEUTICAL FOR TREATING OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS | TROPHIX NEUROSCIENCE INC. (US) | 1997-12-04 | — | — | WO | disclosed |
| EP-0789564-A1 | POLYNUCLEOTIDE COMPOSITIONS | SUPRATEK PHARMA, INC. (CA) | 1997-08-20 | — | — | EP | disclosed |
| US-5656611-A | MODIFIED POLYNUCLEOTIDE AND COPOLYMER HAVING POLYETHER SEGMENTS AND POLYCATION SEGMENTS; STABILIZING POLYNUCLEIC ACIDS AND INCREASING ABILITY TO CROSS CELL MEMBRANES | SUPRATEK PHARMA INC. (CA) | 1997-08-12 | — | — | US | disclosed |
| WO-1996040056-A1 | POLYETHER BLOCK COPOLYMER MICELLAR COMPOSITIONS FOR TARGETING BIOLOGICAL AGENTS | SUPRATEK PHARMA INC. (CA) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996030052-A1 | LIMBIC SYSTEM-ASSOCIATED MEMBRANE PROTEIN AND DNA | UMDNJ, NEW JERSEY'S UNIVERSITY OF THE HEALTH SCIENCES (US) | 1996-10-03 | — | — | WO | disclosed |
| WO-1996024371-A1 | MULTIFUNCTIONAL ENZYME | PHAIRSON MEDICAL, INC. (SE) | 1996-08-15 | — | — | WO | disclosed |
| JP-H08182643-A | WET ADSORBING MATERIAL FOR CLEANING PRODUCT AND SURFACE | YISSUM RES DEV CO OF HEBREW UNIV OF JERUSALEM | 1996-07-16 | — | — | JP | disclosed |
| WO-1996016541-A1 | POLYMER LINKED BIOLOGICAL AGENTS | SUPRATEK PHARMA, INC. (CA) | 1996-06-06 | — | — | WO | disclosed |
| WO-1996015778-A1 | POLYNUCLEOTIDE COMPOSITIONS | SUPRATEK PHARMA, INC. (CA) | 1996-05-30 | — | — | WO | disclosed |